NASDAQ: PASGPassage Bio Inc Stock Ownership - Who owns Passage Bio?
Insider buying vs selling
Have Passage Bio Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Kathleen Borthwick | SVP INTERIM CFO | 2024-02-13 | 1,470 | $0.97 | $1.43kSell |
| Mark S. Forman | CHIEF MEDICAL OFFICER | 2024-02-13 | 1,638 | $0.97 | $1.59kSell |
| Edgar B. Cale | GC Corporate Secretary | 2024-01-02 | 15,813 | $0.91 | $14.39kSell |
| Mark S. Forman | Chief Medical Officer | 2024-01-02 | 15,813 | $0.91 | $14.39kSell |
| Kathleen Borthwick | SVP Interim CFO | 2024-01-02 | 10,672 | $0.91 | $9.71kSell |
| Simona King | Chief Financial Officer | 2023-07-28 | 11,453 | $0.88 | $10.08kSell |
| Orbimed Advisors LLC | 10% Owner | 2023-06-28 | 575,195 | $0.84 | $483.16kBuy |
| Orbimed Advisors LLC | 10% Owner | 2023-06-27 | 617,382 | $0.84 | $518.60kBuy |
| Alexandros Fotopoulos | Chief Technical Officer | 2023-06-16 | 4,052 | $0.93 | $3.78kSell |
| Simona King | Chief Financial Officer | 2023-04-18 | 2,053 | $1.05 | $2.16kSell |
PASG insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when PASG insiders and whales buy or sell their stock.
PASG Shareholders
What type of owners hold Passage Bio Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Orbimed Advisors LLC | 25.15% | 13,981,323 | $18.73M | Insider |
| Orbimed Advisors LLC | 18.21% | 10,124,576 | $13.57M | Institution |
| Frazier Life Sciences Ix LP | 9.01% | 5,009,219 | $6.71M | Insider |
| Patrick J. Heron | 9.01% | 5,009,219 | $6.71M | Insider |
| Thomas Woiwode | 8.92% | 4,959,769 | $6.65M | Insider |
| Versant Venture Management LLC | 8.92% | 4,959,769 | $6.65M | Institution |
| Versant Venture Capital Vi LP | 8.92% | 4,959,769 | $6.65M | Insider |
| Liam Ratcliffe | 4.71% | 2,619,430 | $3.51M | Insider |
| New Leaf Venture Partners LLC | 4.49% | 2,497,922 | $3.35M | Institution |
| Tang Capital Management LLC | 4.32% | 2,400,000 | $3.22M | Institution |
PASG vs Biotech Stocks
Passage Bio Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.